2020 SPEAKERS

Brian Abramson, Treatise author, Bloomberg Law

Brian Abramson | Treatise author | Bloomberg Law » speaking at Vaccine West Coast

David Apiyo, Senior Manager, Applications, Sartorius Stedim Biotech

Philip Arlen, President And Chief Executive Officer, Precision Biologics Inc

Philip Arlen | President And Chief Executive Officer | Precision Biologics Inc » speaking at Vaccine West Coast

Phyllis Arthur, Vice President, Infectious Diseases And Diagnostics Policy, Biotechnology Innovation Organization (BIO)

Phyllis Arthur | Vice President, Infectious Diseases And Diagnostics Policy | Biotechnology Innovation Organization (BIO) » speaking at Vaccine West Coast

Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences

Mario Barro, Avp And Head Of Flunxt Advanced Research, Sanofi Pasteur

Mario Barro | Avp And Head Of Flunxt Advanced Research | Sanofi Pasteur » speaking at Vaccine West Coast

Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories

Sharon Benzeno, Chief Business Development Officer, Adaptive Biotechnologies

Ami Bhatt, Assistant Professor, Medicine - Med/Hematology, Stanford University School of Medicine

Margaret Billingsley, Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania

Margaret Billingsley | Department of Bioengineering, School of Engineering and Applied Science | University of Pennsylvania » speaking at Vaccine West Coast

Cedric Bogaert, CEO, myNEO - Tumour ImmunoEngine

Cedric Bogaert | CEO | myNEO - Tumour ImmunoEngine » speaking at Vaccine West Coast

Chris Bond, Vice President, Cell Engineering, Kite Pharma, a Gilead Company

Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine

Maria Elena Bottazzi | Co-Director, Texas Children’s Hospital Center for Vaccine Development | Baylor College of Medicine » speaking at Vaccine West Coast

Michaela Bowden, Executive Director, Translational Medicine, Bristol-Myers Squibb

Manuel Brantner, Associate Director, Vaccines & Plasma Segment, EMEA, Merck

Lisa Butterfield, Vice President, Research & Development, Parker Institute for Cancer Immunotherapy

Sarah Carqueville, Product Manager, CellGenix

Sarah Carqueville | Product Manager | CellGenix » speaking at Vaccine West Coast

John Connolly, Chief Scientific Officer, Parker Institute for Cancer Immunotherapy

John Connolly | Chief Scientific Officer | Parker Institute for Cancer Immunotherapy » speaking at Vaccine West Coast

Lindsay Cowell, Assistant Professor, Division of Biomedical Informatics, UT Southwestern Medical Center

Shane Crotty, Professor, Division Of Vaccine Discovery, La Jolla Institute for Allergy and Immunology

James Crowe, Director Of Vanderbilt Vaccine Center, VANDERBILT UNIVERSITY MEDICAL CENTER

Kerry Culm-Merdek, Vice President, Clinical Development,, OncXerna

Mark M Davis, Professor, Microbiology And Immunology, Director, Stanford Institute For Immunity, Transplantation And Infection, Stanford University School of Medicine

Michel De Wilde, Former Senior Vice President R&D Of Sanofi Pasteur & Owner, MDW Consultant LLC

Michel De Wilde | Former Senior Vice President R&D Of Sanofi Pasteur & Owner | MDW Consultant LLC » speaking at Vaccine West Coast

Robert Durham, Director of Field Applications Scientists, North America, Gyros Protein Technologies

Robert Durham | Director of Field Applications Scientists, North America | Gyros Protein Technologies » speaking at Vaccine West Coast

Dr Nargisse El Hajjami, Associate Director, Segment Development for Cell and Gene Therapy, EMEA, Merck

Gary Eldridge, President And Chief Executive Officer, Sequoia Sciences Inc

Gary Eldridge | President And Chief Executive Officer | Sequoia Sciences Inc » speaking at Vaccine West Coast

Michael Fehlings, Co-founder / Director Scientific Affairs, immunoSCAPE Pte Ltd

Olja Finn, Distinguished Professor, Department of Immunology, University of Pittsburgh

Olja Finn | Distinguished Professor, Department of Immunology | University of Pittsburgh » speaking at Vaccine West Coast

Joanne Flynn, Professor, University of Pittsburgh School of Medicine

Joanne Flynn | Professor | University of Pittsburgh School of Medicine » speaking at Vaccine West Coast

Bernard Fox, CEO of Ubivac & Chief, Lab of Molecular and Tumor Immunology, Oregon Health & Science University

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK

Christiane Geiger, Director, Medigene Immunotherapies GmbH

Christiane Geiger | Director | Medigene Immunotherapies GmbH » speaking at Vaccine West Coast

Farshad Guirakhoo, CSO, Covaxx

Priti Hegde, CSO, Foundation Medicine Inc

Stephen Hoffman, Chief Executive And Scientific Officer, Sanaria

Stephen Hoffman | Chief Executive And Scientific Officer | Sanaria » speaking at Vaccine West Coast

Douglas Holtzman, Chief Scientific Officer, Icosavax

Douglas Holtzman | Chief Scientific Officer | Icosavax » speaking at Vaccine West Coast

Peter Hotez, Dean, National School Of Tropical Medicine, Director, Texas Children's Hospital Center, Baylor College of Medicine

Peter Hotez | Dean, National School Of Tropical Medicine, Director, Texas Children's Hospital Center | Baylor College of Medicine » speaking at Vaccine West Coast

David Jackson, US Medical Clinical Pharmacology Global Lead, Lundbeck Pharmaceuticals

David Jackson | US Medical Clinical Pharmacology Global Lead | Lundbeck Pharmaceuticals » speaking at Vaccine West Coast

Hong Jiang, COO, Aegis Life, Inc.

Karin Jooss, CSO, Gritstone Oncology

Robert Juba, Senior Vice President of Biological Manufacturing and Clinical Supply Management, Inovio

Maria Karasarides, Vice-President, Head Early Assets & Biomarkers, Bristol-Myers Squibb

Ruth Karron, Professor, Johns Hopkins Bloomberg School of Public Health

Ruth Karron | Professor | Johns Hopkins Bloomberg School of Public Health » speaking at Vaccine West Coast

Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Hans S Keirstead | Chief Executive Officer | AIVITA Biomedical, Inc. » speaking at Vaccine West Coast

Bruce Keyt, CSO, IgM. Biosciences Inc

Bruce Keyt | CSO | IgM. Biosciences Inc » speaking at Vaccine West Coast

Kevin Killeen, Chief Scientific Officer, Matrivax R & D Corp

Kevin Killeen | Chief Scientific Officer | Matrivax R & D Corp » speaking at Vaccine West Coast

Andreas Kuhn, Senior Vice President & Head of RNA Biochemistry & Manufacturing, BioNTech Ag

Theresa Lavallee, VP Translational Medicine and Regulatory Affairs, Parker Institute for Cancer Immunotherapy

James A Lederer, Associate Professor, Department of Surgery, Harvard Medical School Brigham and Women's Hospital

James A Lederer | Associate Professor, Department of Surgery | Harvard Medical School Brigham and Women's Hospital » speaking at Vaccine West Coast

John Lewis, CEO, Aegis Life, Inc.

Daniel Lingwood, Assistant Professor Of Medicine, Harvard Medical School

Daniel Lingwood | Assistant Professor Of Medicine | Harvard Medical School » speaking at Vaccine West Coast

Cheng Liu, Founder And Chief Executive Officer, Eureka Therapeutics

Pedro Madureira, CSO, Immunethep SA

Pedro Madureira | CSO | Immunethep SA » speaking at Vaccine West Coast

Holden T Maecker, Director Immune Monitoring Core, stanford university

Bonnie Maldonado, Professor, Stanford University School of Medicine

Marc Mansour, Chief Scientific Officer, Vaximm AG

Lilith Mist, CRD, Merck Research Laboratories

Lilith Mist | CRD | Merck Research Laboratories » speaking at Vaccine West Coast

Lenny Moise, Director of Vaccine Research, EpiVax Inc

Lenny Moise | Director of Vaccine Research | EpiVax Inc » speaking at Vaccine West Coast

Pedro Moro, Medical Epidemiologist, ISO/CDC

Pedro Moro | Medical Epidemiologist | ISO/CDC » speaking at Vaccine West Coast

Flor Munoz-Rivas, Assistant Professor Of Pediatrics-Infectious Disease, Baylor College of Medicine

Flor Munoz-Rivas | Assistant Professor Of Pediatrics-Infectious Disease | Baylor College of Medicine » speaking at Vaccine West Coast

Morten Nielsen, Groupleader, Professor, Department of Health Technology · Bioinformatics · Immunoinformatics and Machine Learning, Technical University of Denmark

Morten Nielsen | Groupleader, Professor, Department of Health Technology · Bioinformatics · Immunoinformatics and Machine Learning | Technical University of Denmark » speaking at Vaccine West Coast

Inna Ovsyannikova, Professor Of Medicine, Mayo Foundation For Medical Education and Research

Inna Ovsyannikova | Professor Of Medicine | Mayo Foundation For Medical Education and Research » speaking at Vaccine West Coast

Vikram Paradkar, Senior Vice President, Technical Operations, BIOLOGICAL E LIMITED

Vikram Paradkar | Senior Vice President, Technical Operations | BIOLOGICAL E LIMITED » speaking at Vaccine West Coast

Jason Paragas, Former VP Health Innovation, Valo Health; Advisor, Social Impact Capital

Nikolai Petrovsky, Chairman, Vaxine Pty.

Nikolai Petrovsky | Chairman | Vaxine Pty. » speaking at Vaccine West Coast

Krishna Prasad, Founder, Citranvi Biosciences LLC

Lois Privor-Dumm, Director, Policy, Advocacy And Communications, Ivac, Johns Hopkins Bloomberg School of Public Health

Lois Privor-Dumm | Director, Policy, Advocacy And Communications, Ivac | Johns Hopkins Bloomberg School of Public Health » speaking at Vaccine West Coast

Haley Pugsley, Manager, Senior Scientist, Amnis Flow Cytometry, Luminex Corporation

Haley Pugsley | Manager, Senior Scientist, Amnis Flow Cytometry | Luminex Corporation » speaking at Vaccine West Coast

Vasu Rangadass, President & CEO, L7 Informatics

Jessicca Rege, Vice President Oncology R&D, Alkermes

Shon Remich, Senior Director, Vaccine Clinical Research And Development, Pfizer

Shon Remich | Senior Director, Vaccine Clinical Research And Development | Pfizer » speaking at Vaccine West Coast

Douglas Richman, Director, Center for Aids Research, University of California San Diego

Jeff Roberts, Associate Director For Scientific Affairs, FDA

Harlan Robins, CSO, Adaptive Biotechnologies

David Robinson, Deputy Director, CMC Vaccines Development and Surveillance, Bill & Melinda Gates Foundation

David Robinson | Deputy Director, CMC Vaccines Development and Surveillance | Bill & Melinda Gates Foundation » speaking at Vaccine West Coast

Glenn Rockman, Founder And Managing Partner, Adjuvant Capital

Glenn Rockman | Founder And Managing Partner | Adjuvant Capital » speaking at Vaccine West Coast

Sarah Royalty Tredo, Director, Emergent BioSolutions

Sarah Royalty Tredo | Director | Emergent BioSolutions » speaking at Vaccine West Coast

Luis Ruiz, CEO, Ruti Immun

Luis Ruiz | CEO | Ruti Immun » speaking at Vaccine West Coast

Roxana Rustomjee, Senior Vice President Research and Development, Sabin Vaccine Institute

Roxana Rustomjee | Senior Vice President Research and Development | Sabin Vaccine Institute » speaking at Vaccine West Coast

Michael Salgaller, Supervisor, Invention Development And Marketing Unit, National cancer institute

Michael Salgaller | Supervisor, Invention Development And Marketing Unit | National cancer institute » speaking at Vaccine West Coast

Laura Saward, Senior Vice President Of Antibody Therapeutics, Emergent BioSolutions

Laura Saward | Senior Vice President Of Antibody Therapeutics | Emergent BioSolutions » speaking at Vaccine West Coast

David Schaer, Translational Oncology Lead And Director, Pfizer

Mark Schleiss, Department Of Pediatrics Professor, University of Minnesota

Mark Schleiss | Department Of Pediatrics Professor | University of Minnesota » speaking at Vaccine West Coast

Jamie Scott, Professor Emerita, Health Sciences, Simon Fraser Universtiy

Jamie Scott | Professor Emerita, Health Sciences | Simon Fraser Universtiy » speaking at Vaccine West Coast

Martina Sersch, Chief Medical Officer, Gracell Biotechnology

Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Institute for Allergy and Immunology

Aiman Shalabi, Vice President, Medicine Development Leader Cell Therapies R&D, Ny-Eso Tcr-T, GlaxoSmithKline

John Shon, CTO, Serimmune

Jeffrey Skolnik, Senior Vice President Of Clinical Development, Inovio Pharmaceuticals

Nate Spangler, Director, Innovation and Strategy, Aldevron

Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, MSD

Julia Spencer | Associate Vice President, Global Vaccine Public Policy, Partnerships | MSD » speaking at Vaccine West Coast

Roger Swartz, President, Immunofuse

Roger Swartz | President | Immunofuse » speaking at Vaccine West Coast

Christopher Tan, Director, Business Development and Licensing, Search and Evaluation, Infectious Diseases and Vaccines, MERCK

Christopher Tan | Director, Business Development and Licensing, Search and Evaluation, Infectious Diseases and Vaccines | MERCK » speaking at Vaccine West Coast

Magdalena Tary-Lehmann, Chief Scientific Officer, CTL Cellular Technology Ltd

Pascal Touchon, President, Chief Executive Officer And Board Member, Atara Biotherapeutics

James Wassil, Chief Operating Officer, Vaxcyte

Mark Wissel, Director, Viracor Eurofins

Mark Wissel | Director | Viracor Eurofins » speaking at Vaccine West Coast

Lauren V Wood, Chief Medical Officer, P.D.S. Biotechnology Corp

Ashley Wozniak, Interim VP R&D/ Sr Director Marketing, Therapeutics, Emergent BioSolutions

Ashley Wozniak | Interim VP R&D/ Sr Director Marketing, Therapeutics | Emergent BioSolutions » speaking at Vaccine West Coast

Mahesh Yadav, Senior Scientist, Genentech

Roman Yelensky, Executive Vice President And Chief Technology Officer, Gritstone Oncology

Jenny Yip, Managing Partner, Adjuvant Capital

Jenny Yip | Managing Partner | Adjuvant Capital » speaking at Vaccine West Coast

Lei Zheng, Co-director, Pancreatic Cancer Precision Medicine Center of Excellence Program, Johns Hopkins Medicine

Enrique Zudaire, Scientific Director, Head of Immune Oncology Translational Research, Janssen Pharmaceutical

Enrique Zudaire | Scientific Director, Head of Immune Oncology Translational Research | Janssen Pharmaceutical » speaking at Vaccine West Coast